Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Boyett

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Blood|June 19, 2002
Persistence of lymphoblasts in bone marrow on day 15 and days 22 to 25 of remission induction predicts a dismal treatment outcome in children with acute lymphoblastic leukemiaJohn T Sandlund, Patricia L Harrison, Gaston Rivera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Neurocognitive consequences of risk-adapted therapy for childhood medulloblastomaRaymond K Mulhern, Shawna L Palmer, Thomas E Merchant, et al.
Nursing Open|November 28, 2022
A systematic review and meta-analysis: Assessment of hospital walking programs among older patientsChristine Loyd, Yue Zhang, Tara Weisberg, et al.
Physiological Reports|May 5, 2026
Adipocyte-specific FFA2 deletion leads to increased adipose inflammation and is associated with altered intestinal lipid handling in miceChioma Nnyamah, James Boyett, Barton Wicksteed, et al.
Neuro-Oncology|June 9, 2014
A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a pediatric brain tumor consortium reportJack M Su, Patrick Thompson, Adekunle Adesina, et al.
Journal of Neuro-Oncology|June 29, 2016
A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium studyRalph Salloum, Trent R Hummel, Shiva Senthil Kumar, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Blood|June 19, 2002
Persistence of lymphoblasts in bone marrow on day 15 and days 22 to 25 of remission induction predicts a dismal treatment outcome in children with acute lymphoblastic leukemiaJohn T Sandlund, Patricia L Harrison, Gaston Rivera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Neurocognitive consequences of risk-adapted therapy for childhood medulloblastomaRaymond K Mulhern, Shawna L Palmer, Thomas E Merchant, et al.
Nursing Open|November 28, 2022
A systematic review and meta-analysis: Assessment of hospital walking programs among older patientsChristine Loyd, Yue Zhang, Tara Weisberg, et al.
Physiological Reports|May 5, 2026
Adipocyte-specific FFA2 deletion leads to increased adipose inflammation and is associated with altered intestinal lipid handling in miceChioma Nnyamah, James Boyett, Barton Wicksteed, et al.
Neuro-Oncology|June 9, 2014
A phase I trial of veliparib (ABT-888) and temozolomide in children with recurrent CNS tumors: a pediatric brain tumor consortium reportJack M Su, Patrick Thompson, Adekunle Adesina, et al.
Journal of Neuro-Oncology|June 29, 2016
A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium studyRalph Salloum, Trent R Hummel, Shiva Senthil Kumar, et al.
Pageof 2